Relationships of thrombosis and fibrinolysis to atherosclerosis

A Hamsten1, P Eriksson, F Karpe

  • 1King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden.

Insights

The haemostatic system significantly impacts coronary heart disease risk. Advances reveal how hypercoagulability and impaired fibrinolysis, linked to dyslipoproteinaemia and insulin resistance, contribute to heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Haematology
  • Metabolic Disorders

Background:

  • The haemostatic system's role in coronary heart disease (CHD) is increasingly recognized.
  • Understanding mechanisms of hypercoagulability and impaired fibrinolysis is crucial for CHD prevention.
  • Dyslipoproteinaemia and insulin resistance are implicated in thrombotic processes relevant to CHD.

Purpose of the Study:

  • To review the current understanding of the haemostatic system's contribution to coronary heart disease.
  • To highlight key mechanisms leading to a prothrombotic state.
  • To emphasize the link between metabolic factors and cardiovascular risk.

Main Methods:

  • Literature review focusing on haemostasis, thrombosis, and coronary heart disease.
  • Analysis of recent research on hypercoagulability and fibrinolytic dysfunction.
  • Synthesis of evidence linking dyslipoproteinaemia and insulin resistance to haemostatic changes.

Main Results:

  • The haemostatic system plays a significant role in the pathogenesis of coronary heart disease.
  • Hypercoagulability and impaired fibrinolytic function are key mechanisms predisposing to CHD.
  • Dyslipoproteinaemia and insulin resistance are strongly associated with these haemostatic abnormalities.

Conclusions:

  • The haemostatic system is a critical factor in coronary heart disease development.
  • Targeting hypercoagulability and fibrinolysis may offer new therapeutic strategies for CHD.
  • Metabolic factors like dyslipoproteinaemia and insulin resistance are important considerations in managing cardiovascular risk.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...